Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth (CROSBI ID 293182)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Kamposioras, Konstantinos ; Mauri, Davide ; Papadimitriou, Konstantinos ; Anthoney, Alan ; Hindi, Nadia ; Petricevic, Branka ; Dambrosio, Mario ; Valachis, Antonis ; Kountourakis, Pantelis ; Kopecky, Jindrich ; Kuhar, Cvetka Grašič ; Popovic, Lazar ; Chilingirova, Nataliya P. ; Zarkavelis, George ; de Mello, Ramon Andrade ; Dedić Plavetić, Natalija ; Christopoulos, Christos ; Mostert, Bianca ; Goffin, John R. ; Tzachanis, Dimitiros ; Saraireh, Haytham Hamed ; Ma, Fei ; Pavese, Ida ; Tolia, Maria
engleski
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth
Introduction: Pandemic COVID-19 is an unexpected challenge for the oncological community, indicating potential detrimental effects on cancer patients. Our aim was to summarize the converging key points providing a general guidance in order to support decision making, pertaining to the oncologic care in the middle of a global outbreak. Methods: We did an international online search in twenty five countries that have managed a surge in cancer patient numbers. We collected the recommendations from thirty one medical oncology societies. Results: By synthesizing guidelines for a) oncology service delivery adjustments, b) general and specific treatment adaptations, and c) discrepancies from guidelines comparison, we present a clinical synopsis with the forty more crucial statements. A Covid-19 risk stratification base was also created in order to obtain a quick, objective patient assessment and a risk-benefit evaluation on a case- by-case basis. Conclusions: In an attempt to face these complex needs and due to limited understanding of COVID-19, a variability of recommendations based on general epidemiological and infectious disease principles rather than definite cancer-related evidence has evolved. Additionally, the absence of an effective treatment or vaccine requires the development of cancer management guidance, capitalizing on comprehensive COVID-19 oncology experience globally.
COVID-19 ; oncology ; guidelines
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kliničke medicinske znanosti